CPT code 21030 denotes enucleation and/or curettage for removal of benign tumors of the upper jaw (maxilla) and cheekbone (zygoma). This code captures a targeted maxillofacial surgical procedure and is relevant to surgical, dental-maxillofacial, and otolaryngology service lines. It matters nationally because it represents a discrete, often inpatient or ambulatory-surgical setting procedure that drives surgical resource use, anesthesia planning, and post-op care pathways for nonmalignant craniofacial tumors.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find clinical context for when enucleation and curettage are appropriate for benign maxillofacial lesions, typical sites of service, and the procedural scope captured by the code. The publication outlines benchmarks and payment context where available, common billing considerations, and potential policy updates that affect coverage and coding practice.

The report serves clinicians, billing professionals, and policy analysts seeking a concise reference on procedural definition, setting expectations for site-of-service, and the payer landscape nationally. Data not available in the input is noted where specific benchmarks, associated taxonomies, or ICD-10 mappings would normally be provided.